These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1389110)

  • 1. Report of a collaborative study to assess the determination of glycoprotein antigen content of rabies vaccines for human use.
    Ferguson M; Heath A
    Biologicals; 1992 Jun; 20(2):143-54. PubMed ID: 1389110
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel in vitro ELISA for estimation of glycoprotein content in human rabies vaccines.
    Aavula SM; Abhinay G; Nimmagadda SV; Maithal K
    J Immunoassay Immunochem; 2017; 38(4):400-410. PubMed ID: 28436708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A collaborative study on the use of single radial immunodiffusion for the assay of rabies virus glycoprotein.
    Ferguson M; Seagroatt V; Schild GC
    J Biol Stand; 1984 Jul; 12(3):283-94. PubMed ID: 6434544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of rabies virus N protein in rabies vaccines.
    Montaño-Hirose JA; Lafage M; Lafon M
    Res Virol; 1995; 146(3):217-24. PubMed ID: 7481094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of rabies antigen by ELISA.
    van der Marel P; van Wezel AL
    Dev Biol Stand; 1981; 50():267-75. PubMed ID: 7341294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neuraminidase in duck embryo rabies vaccine.
    Kuwahara SS; Burgoyne GH
    Health Lab Sci; 1978 Oct; 15(4):201-5. PubMed ID: 744719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single radial immunodiffusion assays for the standardization of the antigenic content of rabies vaccines.
    Ferguson M; Seagroatt V; Schild GC
    Dev Biol Stand; 1986; 64():81-6. PubMed ID: 3098607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release.
    Gibert R; Alberti M; Poirier B; Jallet C; Tordo N; Morgeaux S
    Vaccine; 2013 Dec; 31(50):6022-9. PubMed ID: 24161572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen content versus volume of rabies vaccines administered intradermally.
    Dodet B
    Biologicals; 2011 Nov; 39(6):444-5. PubMed ID: 22000166
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of various immunochemical, biochemical and biological methods for the analysis of rabies virus production in tissue cultures.
    Adamovicz P; Aguilon F; David A; Le Fur R; Mazert MC; Perrin P; Reculard P; Sureau P
    Dev Biol Stand; 1983; 55():191-7. PubMed ID: 6677532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture.
    Nagarajan T; Reddy GS; Mohana Subramanian B; Rajalakshmi S; Thiagarajan D; Tordo N; Jallet C; Srinivasan VA
    Biologicals; 2006 Mar; 34(1):21-7. PubMed ID: 16188454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use.
    Abhinay G; Dessain S; Srikanth A; Senthilkumar RL; Vidyasagar P; Praveen A; Chandrasekhar Reddy RV; Swapna Reddy E; Rajendra L
    Vaccine; 2014 Jan; 32(2):209-13. PubMed ID: 24262315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies.
    Ferguson M; Schild GC
    J Gen Virol; 1982 Mar; 59(Pt 1):197-201. PubMed ID: 6802936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a relative potency test using ELISA for human rabies vaccines.
    Wang Z; Sun Y; Wu X; Carroll DS; Lv W; You L; Ji Y; Shi J; Yan J; Xu G; Meng S
    Biologicals; 2018 Sep; 55():59-62. PubMed ID: 29970288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabies vaccines.
    Turner GS
    Br Med Bull; 1969 May; 25(2):136-42. PubMed ID: 4918529
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
    Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M
    Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an enzyme immunoassay with protein A for rabies antigen and antibody determination.
    Atanasiu P; Perrin P; Delagneau JF
    Dev Biol Stand; 1980; 46():207-15. PubMed ID: 6988255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization schedules for the new human diploid cell vaccine against rabies.
    Plotkin SA; Wiktor TJ; Koprowski H; Rosanoff EI; Tint H
    Am J Epidemiol; 1976 Jan; 103(1):75-80. PubMed ID: 942811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing.
    Rooijakkers EJ; Uittenbogaard JP; Groen J; Osterhaus AD
    J Virol Methods; 1996 Apr; 58(1-2):111-9. PubMed ID: 8783156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - Results of an international collaborative study.
    Morgeaux S; Poirier B; Ragan CI; Wilkinson D; Arabin U; Guinet-Morlot F; Levis R; Meyer H; Riou P; Shaid S; Volokhov D; Tordo N; Chapsal JM
    Vaccine; 2017 Feb; 35(6):966-971. PubMed ID: 28081969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.